Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ-positive juvenile dermatomyositis.

IF 20.3 1区医学 Q1 RHEUMATOLOGY

Annals of the Rheumatic Diseases Pub Date : 2025-06-01 Epub Date: 2025-04-11 DOI:10.1016/j.ard.2025.02.002

Clément Triaille, Maryam Piram, Benjamin Ellezam, Karine Leveille, Catherine Maari, Amandine Remy, Khampoun Sayasith, Elie Haddad, Marie-Paule Morin

引用次数: 0

查看原文本刊更多论文

anfrolumab在难治性抗tif1 γ阳性青少年皮肌炎中的快速临床和转录组反应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of the Rheumatic Diseases 医学-风湿病学

CiteScore

35.00

自引率

9.90%

发文量

3728

审稿时长

1.4 months

期刊介绍： Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.